JPS62243602A - シクロデキストリンの改質方法 - Google Patents
シクロデキストリンの改質方法Info
- Publication number
- JPS62243602A JPS62243602A JP62070159A JP7015987A JPS62243602A JP S62243602 A JPS62243602 A JP S62243602A JP 62070159 A JP62070159 A JP 62070159A JP 7015987 A JP7015987 A JP 7015987A JP S62243602 A JPS62243602 A JP S62243602A
- Authority
- JP
- Japan
- Prior art keywords
- cyclodextrin
- beta
- carbonate
- reaction mixture
- alkylene carbonate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920000858 Cyclodextrin Polymers 0.000 title claims description 65
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 title claims description 26
- 230000004048 modification Effects 0.000 title description 12
- 238000012986 modification Methods 0.000 title description 12
- 238000006243 chemical reaction Methods 0.000 claims description 34
- -1 alkylene carbonate Chemical compound 0.000 claims description 29
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 29
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims description 26
- 229960004853 betadex Drugs 0.000 claims description 25
- 239000001116 FEMA 4028 Substances 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 23
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 239000011541 reaction mixture Substances 0.000 claims description 14
- 239000003054 catalyst Substances 0.000 claims description 10
- KMTRUDSVKNLOMY-UHFFFAOYSA-N Ethylene carbonate Chemical group O=C1OCCO1 KMTRUDSVKNLOMY-UHFFFAOYSA-N 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical group [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 8
- 229940097362 cyclodextrins Drugs 0.000 claims description 6
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims description 6
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 claims description 5
- RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical group CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 claims description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 4
- 150000002170 ethers Chemical class 0.000 claims 2
- 238000010438 heat treatment Methods 0.000 claims 1
- 229920002472 Starch Polymers 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 235000019698 starch Nutrition 0.000 description 9
- 239000008107 starch Substances 0.000 description 8
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 5
- 229940080345 gamma-cyclodextrin Drugs 0.000 description 5
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 4
- 229940043377 alpha-cyclodextrin Drugs 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 238000006266 etherification reaction Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000002002 slurry Substances 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 238000004042 decolorization Methods 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000012429 reaction media Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- ZZXUZKXVROWEIF-UHFFFAOYSA-N 1,2-butylene carbonate Chemical compound CCC1COC(=O)O1 ZZXUZKXVROWEIF-UHFFFAOYSA-N 0.000 description 1
- QFHAQSIOWLYFSF-UHFFFAOYSA-N 1-(1-hydroxyethoxy)ethanol Chemical compound CC(O)OC(C)O QFHAQSIOWLYFSF-UHFFFAOYSA-N 0.000 description 1
- AZUXKVXMJOIAOF-UHFFFAOYSA-N 1-(2-hydroxypropoxy)propan-2-ol Chemical compound CC(O)COCC(C)O AZUXKVXMJOIAOF-UHFFFAOYSA-N 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- SAQPWCPHSKYPCK-UHFFFAOYSA-N carbonic acid;propane-1,2,3-triol Chemical compound OC(O)=O.OCC(O)CO SAQPWCPHSKYPCK-UHFFFAOYSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 231100000206 health hazard Toxicity 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000002407 reforming Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000003828 vacuum filtration Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/852,630 US4920214A (en) | 1986-04-16 | 1986-04-16 | Process for producing modified cyclodextrins |
| US852630 | 1986-04-16 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS62243602A true JPS62243602A (ja) | 1987-10-24 |
| JPH0140041B2 JPH0140041B2 (enExample) | 1989-08-24 |
Family
ID=25313836
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP62070159A Granted JPS62243602A (ja) | 1986-04-16 | 1987-03-24 | シクロデキストリンの改質方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4920214A (enExample) |
| JP (1) | JPS62243602A (enExample) |
| CA (1) | CA1281320C (enExample) |
| DE (1) | DE3712246A1 (enExample) |
| FR (1) | FR2597485B1 (enExample) |
| GB (1) | GB2189245B (enExample) |
| NL (1) | NL187486C (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9001987D0 (en) * | 1990-01-29 | 1990-03-28 | Janssen Pharmaceutica Nv | Improved cyclodextrin based erythropietin formulation |
| US5137571A (en) * | 1990-06-05 | 1992-08-11 | Rohm And Haas Company | Method for improving thickeners for aqueous systems |
| US5376709A (en) * | 1993-03-12 | 1994-12-27 | Rohm And Haas Company | Method for improving thickeners for aqueous systems |
| DE4401618A1 (de) * | 1994-01-20 | 1995-07-27 | Consortium Elektrochem Ind | Verfahren zur Herstellung von aminofunktionellen Cyclodextrin Derivaten |
| US5492947A (en) * | 1994-06-23 | 1996-02-20 | Aspen Research Corporation | Barrier material comprising a thermoplastic and a compatible cyclodextrin derivative |
| US5985772A (en) * | 1994-06-23 | 1999-11-16 | Cellresin Technologies, Llc | Packaging system comprising cellulosic web with a permeant barrier or contaminant trap |
| US5776842A (en) * | 1994-06-23 | 1998-07-07 | Cellresin Technologies, Llc | Cellulosic web with a contaminant barrier or trap |
| US5928745A (en) * | 1994-06-23 | 1999-07-27 | Cellresin Technologies, Llc | Thermoplastic fuel tank having reduced fuel vapor emissions |
| US5569756A (en) * | 1995-03-21 | 1996-10-29 | American Maize-Products Company | Purification of chemically modified cyclodextrins |
| FR2735136B1 (fr) * | 1995-06-08 | 1997-08-14 | Roquette Freres | Composition pulverulente d'hydroxypropyl-betacyclodextrine et son procede de preparation. |
| US5882565A (en) * | 1995-12-11 | 1999-03-16 | Cellresin Technologies, Llc | Barrier material comprising a thermoplastic and a compatible cyclodextrin derivative |
| US5906981A (en) * | 1996-06-04 | 1999-05-25 | Troy Corporation | Halopropargyl inclusion complexes |
| US6683100B2 (en) | 1999-01-19 | 2004-01-27 | Novartis Ag | Organic compounds |
| US6194181B1 (en) | 1998-02-19 | 2001-02-27 | Novartis Ag | Fermentative preparation process for and crystal forms of cytostatics |
| EP1287039A1 (en) * | 2000-04-28 | 2003-03-05 | University College Dublin | Amphiphilic macrocyclic derivatives and their analogues |
| AU2004226435B2 (en) | 2003-03-28 | 2009-11-12 | Ares Trading S.A. | Cladribine formulations for improved oral and transmucosal delivery |
| RS51115B (sr) | 2003-03-28 | 2010-10-31 | Ares Trading S.A. | Oralne formulacije kladribina |
| UA81305C2 (en) | 2003-07-02 | 2007-12-25 | Ares Trading Sa | Formulation of cladribine (variants), cladribine-cyclodextrin complex, use of cladribine-cyclodextrin complex, mixture |
| JP2007534693A (ja) | 2004-04-23 | 2007-11-29 | サイデックス・インコーポレイテッド | スルホアルキルエーテルシクロデキストリンを含有するｄｐｉ製剤 |
| EP1945228B9 (en) | 2005-10-26 | 2015-03-11 | CyDex Pharmaceuticals, Inc. | Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof |
| US7629331B2 (en) | 2005-10-26 | 2009-12-08 | Cydex Pharmaceuticals, Inc. | Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof |
| US7635773B2 (en) * | 2008-04-28 | 2009-12-22 | Cydex Pharmaceuticals, Inc. | Sulfoalkyl ether cyclodextrin compositions |
| US8492538B1 (en) | 2009-06-04 | 2013-07-23 | Jose R. Matos | Cyclodextrin derivative salts |
| DK3702374T3 (da) | 2012-02-15 | 2022-06-27 | Cydex Pharmaceuticals Inc | Fremsgangsmåde til fremstilling for cyclodextrin-derivater |
| KR20160033795A (ko) | 2012-02-28 | 2016-03-28 | 사이덱스 파마슈티칼스, 인크. | 알킬화된 시클로덱스트린 조성물 및 이의 제조 및 사용 방법 |
| MX2015000813A (es) | 2012-07-18 | 2015-09-07 | Onyx Therapeutics Inc | Composiciones liposómicas de inhibidores de proteasoma basadas en epoxicetona. |
| WO2014066274A1 (en) | 2012-10-22 | 2014-05-01 | Cydex Pharmaceuticals, Inc. | Alkylated cyclodextrin compositions and processes for preparing and using the same |
| WO2015002893A1 (en) * | 2013-07-02 | 2015-01-08 | The Trustees Of Columbia University In The City Of New York | Clearance of bioactive lipids from membrane structures by cyclodextrins |
| US10851184B2 (en) | 2014-08-22 | 2020-12-01 | Cydex Pharmaceuticals, Inc. | Fractionated alkylated cyclodextrin compositions and processes for preparing and using the same |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2448767A (en) * | 1942-12-05 | 1948-09-07 | Mellon Inst Of Ind Res | Process of hydroxyethylation |
| US2819260A (en) * | 1953-06-04 | 1958-01-07 | Petrolite Corp | Process for preparing oxyalkylated derivatives |
| US2767171A (en) * | 1953-11-27 | 1956-10-16 | Gen Mills Inc | Starch carbonate |
| DE1289322B (de) * | 1962-09-20 | 1969-02-13 | Metallgesellschaft Ag | Vorlegierung zur Behandlung von Eisen- und Stahlschmelzen |
| US3459731A (en) * | 1966-12-16 | 1969-08-05 | Corn Products Co | Cyclodextrin polyethers and their production |
| US3453259A (en) * | 1967-03-22 | 1969-07-01 | Corn Products Co | Cyclodextrin polyol ethers and their oxidation products |
| HU181418B (en) * | 1979-12-28 | 1983-07-28 | Chinoin Gyogyszer Es Vegyeszet | Method for isolateing vapours for gas mixture |
| US4474951A (en) * | 1983-09-27 | 1984-10-02 | The Dow Chemical Company | Hydroxyalkylation of polysaccharides |
| EP0146841A3 (de) * | 1983-12-17 | 1986-11-20 | Consortium für elektrochemische Industrie GmbH | Wasserlösliche Mischether des beta-Cyclodextrins und ein Verfahren zu ihrer Herstellung |
| DE3346123A1 (de) * | 1983-12-21 | 1985-06-27 | Janssen Pharmaceutica, N.V., Beerse | Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung |
-
1986
- 1986-04-16 US US06/852,630 patent/US4920214A/en not_active Expired - Fee Related
-
1987
- 1987-02-20 CA CA000530212A patent/CA1281320C/en not_active Expired - Lifetime
- 1987-03-24 JP JP62070159A patent/JPS62243602A/ja active Granted
- 1987-04-08 NL NLAANVRAGE8700830,A patent/NL187486C/xx not_active IP Right Cessation
- 1987-04-10 DE DE19873712246 patent/DE3712246A1/de active Granted
- 1987-04-14 GB GB8708974A patent/GB2189245B/en not_active Expired - Lifetime
- 1987-04-15 FR FR878705372A patent/FR2597485B1/fr not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| NL8700830A (nl) | 1987-11-16 |
| DE3712246A1 (de) | 1987-10-29 |
| DE3712246C2 (enExample) | 1989-10-12 |
| GB2189245B (en) | 1990-02-21 |
| FR2597485B1 (fr) | 1991-12-13 |
| NL187486C (nl) | 1991-10-16 |
| GB8708974D0 (en) | 1987-05-20 |
| FR2597485A1 (fr) | 1987-10-23 |
| GB2189245A (en) | 1987-10-21 |
| CA1281320C (en) | 1991-03-12 |
| JPH0140041B2 (enExample) | 1989-08-24 |
| US4920214A (en) | 1990-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS62243602A (ja) | シクロデキストリンの改質方法 | |
| US4582900A (en) | Water-soluble mixed ethers of β-cyclodextrin and a process for their preparation | |
| US3873614A (en) | Process for preparing oxidized carbohydrates and products | |
| US4281111A (en) | Cold water hydrating starch | |
| JPH0617361B2 (ja) | β‐シクロデキストリンの水溶性エーテルおよびその製法 | |
| JPH02503692A (ja) | 分枝シクロデキストリンの製造方法およびそれによって製造した生成物 | |
| US5756715A (en) | Process for making crystalline iron dextran | |
| JPH0220502A (ja) | 分枝したβ−シクロデキストリンの精製および分離方法 | |
| US3725386A (en) | Method for purifying crude, dry granular reacted cold water swelling hydroxypropyl starch derivatives | |
| US3507855A (en) | Process of preparing cellulose sulfate and starch sulfate | |
| US4584370A (en) | Process for the production of calcium cellulose glycolate | |
| JPS58210901A (ja) | シクロデキストリン誘導体およびその製造方法 | |
| Te Wierik et al. | Preparation, characterization, and pharmaceutical application of linear dextrins. I. Preparation and characterization of amylodextrin, metastable amylodextrins, and metastable amylose | |
| EP0859795B1 (en) | Process for making crystalline iron dextran | |
| CN101300275A (zh) | 用于制备聚葡糖醛酸酐和/或其盐的方法 | |
| US3706731A (en) | Process of preparing highly substituted hydroxyalkyl ethers of uninhibited granule starches substantially free of salts and glycols,and resulting products | |
| US3196146A (en) | Production and recovery of benzyl dextran | |
| JP3002867B2 (ja) | アルキルエーテル化セルロース誘導体の製造方法 | |
| US3208998A (en) | Cyanoethyl amylose derivatives and process for preparing same | |
| JPH0794481B2 (ja) | セルロースエーテルの製造法 | |
| JPS6259601A (ja) | エ−テル化サイクロデキストリンの製造方法 | |
| JPS60155201A (ja) | 化学修飾多糖及びその製造法 | |
| JP2547579B2 (ja) | サイクロデキストリン誘導体含有組成物の製造方法 | |
| US3580903A (en) | Ketodextran compounds | |
| US3313654A (en) | Process for recovering amylose from acid-hydrolyzed starch |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |